Checkpoint Therapeutics Inc (OQ:CKPT)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for CKPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 23rd, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 22/24 Mar 20/24 Fortress Biotech, Inc. Direct Ownership COMMON STOCK, PAR VALUE $0.0001 A - Grant, award or other under Rule 16b-3(d) 193,905  
Mar 19/24 Mar 19/24 Amit Sharma Direct Ownership Common Stock (Restricted) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 1/24 Feb 28/24 Oliviero James F III Direct Ownership COMMON STOCK G - Gift -9,056  
Mar 1/24 Feb 28/24 Oliviero James F III Direct Ownership COMMON STOCK S - Open market or private sale -5,894 $2.06
Mar 1/24 Feb 28/24 Gray William Garrett Direct Ownership Common Stock S - Open market or private sale -2,035 $2.07
Feb 2/24 Feb 1/24 Gray William Garrett Direct Ownership Common Stock S - Open market or private sale -4,115 $1.95
Feb 2/24 Feb 1/24 Oliviero James F III Direct Ownership COMMON STOCK G - Gift -12,950  
Feb 2/24 Feb 1/24 Oliviero James F III Direct Ownership COMMON STOCK S - Open market or private sale -11,900 $2.01
Jan 3/24 Dec 29/23 Fortress Biotech, Inc. Direct Ownership COMMON STOCK, PAR VALUE $0.0001 A - Grant, award or other under Rule 16b-3(d) 158,134  
Sep 26/23 Sep 25/23 Fortress Biotech, Inc. Direct Ownership COMMON STOCK, PAR VALUE $0.0001 A - Grant, award or other under Rule 16b-3(d) 80,906  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CKPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 23rd, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 22/24 Mar 20/24 Fortress Biotech, Inc. Direct Ownership COMMON STOCK, PAR VALUE $0.0001 A - Grant, award or other under Rule 16b-3(d) 193,905  
Mar 19/24 Mar 19/24 Amit Sharma Direct Ownership Common Stock (Restricted) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 1/24 Feb 28/24 Oliviero James F III Direct Ownership COMMON STOCK G - Gift -9,056  
Mar 1/24 Feb 28/24 Oliviero James F III Direct Ownership COMMON STOCK S - Open market or private sale -5,894 $2.06
Mar 1/24 Feb 28/24 Gray William Garrett Direct Ownership Common Stock S - Open market or private sale -2,035 $2.07
Feb 2/24 Feb 1/24 Gray William Garrett Direct Ownership Common Stock S - Open market or private sale -4,115 $1.95
Feb 2/24 Feb 1/24 Oliviero James F III Direct Ownership COMMON STOCK G - Gift -12,950  
Feb 2/24 Feb 1/24 Oliviero James F III Direct Ownership COMMON STOCK S - Open market or private sale -11,900 $2.01
Feb 2/24 Aug 16/23 Oliviero James F III Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -12,510  
Feb 2/24 Feb 24/23 Oliviero James F III Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -42,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CKPT

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.